These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Purpurogallin as an antioxidant protector of human erythrocytes against lysis by peroxyl radicals. Sugiyama H; Fung KP; Wu TW Life Sci; 1993; 53(4):PL39-43. PubMed ID: 8326817 [TBL] [Abstract][Full Text] [Related]
8. Lithospermic acid B as an antioxidant-based protector of cultured ventricular myocytes and aortic endothelial cells of rabbits. Fung KP; Wu J; Zeng LH; Wong HN; Lee CM; Hon PM; Chang HM; Wu TW Life Sci; 1993; 53(12):PL189-93. PubMed ID: 8395629 [TBL] [Abstract][Full Text] [Related]
9. Molecular structure and antioxidant specificity of purpurogallin in three types of human cardiovascular cells. Wu TW; Zeng LH; Wu J; Fung KP; Weisel RD; Hempel A; Camerman N Biochem Pharmacol; 1996 Oct; 52(7):1073-80. PubMed ID: 8831727 [TBL] [Abstract][Full Text] [Related]
10. Morin: a wood pigment that protects three types of human cells in the cardiovascular system against oxyradical damage. Wu TW; Zeng LH; Wu J; Fung KP Biochem Pharmacol; 1994 Mar; 47(6):1099-103. PubMed ID: 8147911 [TBL] [Abstract][Full Text] [Related]
11. Water-soluble antioxidant specificity against free radical injury using cultured human ventricular myocytes and fibroblasts and saphenous vein endothelial cells. Mickle DA; Li RK; Weisel RD; Tumiati LC; Wu TW J Mol Cell Cardiol; 1990 Nov; 22(11):1297-304. PubMed ID: 2283686 [TBL] [Abstract][Full Text] [Related]
12. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Auch-Schwelk W; Katusic ZS; Vanhoutte PM Hypertension; 1989 Jun; 13(6 Pt 2):859-64. PubMed ID: 2567706 [TBL] [Abstract][Full Text] [Related]
14. Effects of oxygen free radicals and scavengers on the cardiac extracellular collagen matrix during ischemia-reperfusion. Lonn E; Factor SM; Van Hoeven KH; Wen WH; Zhao M; Dawood F; Liu P Can J Cardiol; 1994 Mar; 10(2):203-13. PubMed ID: 8143221 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of xanthine oxidase by purpurogallin and silymarin group. Sheu SY; Lai CH; Chiang HC Anticancer Res; 1998; 18(1A):263-7. PubMed ID: 9568088 [TBL] [Abstract][Full Text] [Related]
16. Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from reperfusion injury. Wu TW; Hashimoto N; Au JX; Wu J; Mickle DA; Carey D Hepatology; 1991 Mar; 13(3):575-80. PubMed ID: 1999327 [TBL] [Abstract][Full Text] [Related]
17. Blockade of platelet-mediated relaxation in rat aortic rings exposed to xanthine-xanthine oxidase. Yang BC; Khan S; Mehta JL Am J Physiol; 1994 Jun; 266(6 Pt 2):H2212-9. PubMed ID: 8023984 [TBL] [Abstract][Full Text] [Related]
18. Conversion to purpurogallin, a key step in the mechanism of the potent xanthine oxidase inhibitory activity of pyrogallol. Honda S; Fukuyama Y; Nishiwaki H; Masuda A; Masuda T Free Radic Biol Med; 2017 May; 106():228-235. PubMed ID: 28223196 [TBL] [Abstract][Full Text] [Related]
19. Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system. Berman RS; Martin W Br J Pharmacol; 1993 Apr; 108(4):920-6. PubMed ID: 8485631 [TBL] [Abstract][Full Text] [Related]
20. Effect of xanthine oxidase inhibition on endothelium-dependent and nitrergic relaxations. Ellis A; Li CG; Rand MJ Eur J Pharmacol; 1998 Aug; 356(1):41-7. PubMed ID: 9761422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]